US chemistry firm PharmaTek Laboratories has a green light to start making high potency APIs and cytotoxics at its facility in California after meeting strict safety and control rules that govern their production.
Drug delivery specialist Hospira has set up a “biologics clock” that counts the amount spent on cell culture-derived medications in the US in a bid to highlight the potential savings greater use of generics could provide.
Copley Scientific is expanding its range of nebuliser testing equipment by launching its NGI Cooler, which has been developed in light of suggested revisions to aerosol monographs on both sides of the Atlantic.
Contract pharmaceutical services provider Catalent is to install a 10 colour press at its printed components facility in the Irish capital Dublin as part of a company wide effort to expand European operations.
Althea Technologies’ biologics and injectables contract development, manufacturing and testing facility in San Diego, US is open for business, bringing to an end the firm’s two year campaign to expand capacity.